Drug Development Consulting BidCo ApS: Financial statements 2025
CVR: 42287067
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Drug Development Consulting BidCo ApS (CVR 42287067) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,875,000 and a net result of DKK -61,325,000 compared with DKK -13,215,000 the year before. That is an increase of 70.9% compared with the year before. Equity in the 2025 report amounted to DKK 32,493,000. The solvency ratio was 35.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 5,875,000
- Profit/Loss
- DKK -61,325,000
- Equity
- DKK 32,493,000
- Total Assets
- DKK 92,013,000
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 5.9M | -61.3M | 32.5M | 2 |
| 2024 | - | 3.4M | -13.2M | 79M | 1 |
| 2023 | - | 2.3M | -9.4M | 70.2M | 1 |
| 2022 | - | 3.8M | -11.8M | 71.8M | 1 |
Official annual report
How creditworthy is Drug Development Consulting BidCo ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Drug Development Consulting BidCo ApS has published its annual report for 2024. Gross profit came to DKK 3,438,000, and the net result was DKK -13,215,000.
As of February 28, 2025, Rasmus Koch Nelund has stepped down as director of Drug Development Consulting BidCo ApS.
About Drug Development Consulting BidCo ApS
Drug Development Consulting BidCo ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of René Holmen Pedersen. The board consists of Niels Peder Nielsen (chair), Alejandra Maria Cristina Bonifacini Mørk, Rafael Natanek and Redmar Koene. The company is owned by Drug Development Consulting Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 5,875,000 and a net result of DKK -61,325,000 compared with DKK -13,215,000 the year before. Equity in the 2025 report amounted to DKK 32,493,000.
